Mi SciELO
Servicios personalizadosServicios Personalizados
Revista
Articulo
Español (pdf)
Articulo en XML
Referencias del artículo
Traducción automática
Enviar articulo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Citado por Google 
Similares en
SciELO 
Similares en Google
Compartir
Permalink
Nefrología (Madrid)
versión On-line ISSN 1989-2284versión impresa ISSN 0211-6995
Resumen
RODRIGUEZ-OSORIO, Laura et al. Differences between 2nd and 3rd generation seric parathormone determination methods on mortality in haemodialysis patients. Nefrología (Madr.) [online]. 2017, vol.37, n.4, pp.389-396. ISSN 1989-2284. https://dx.doi.org/10.1016/j.nefro.2016.11.021.
Parathormone plays a key role in controlling mineral metabolism. PTH is considered a uremic toxin causing cardiovascular damage and cardiovascular mortality in dialysis patients. There are two different assays to measure PTH called 2nd generation or intact PTH (iPTH) and 3rd generation or bioPTH (PTHbio).
Objective:
To evaluate the differences in mortality of dialysis patients between both assays to measure PTH, as well as the possible prognostic role of the PTHbio/iPTH ratio.
Methods:
145 haemodialysis patients were included with 2-year monitoring including baseline laboratory test and annually thereafter.
Results:
21 patients died in the first year and 28 in the second. No correlation was found between PTH, PTHbio and PTHbio/iPTH ratio with mortality. Both PTH have a perfect correlation between them and correlate similarly with other molecules of the mineral metabolism. The extreme baseline values of PTH are those of higher mortality. In survival by iPTH intervals (according to guidelines and COSMOS study), a J curve is observed. When iPTH increases, the ratio decreases, possibly when increasing fragments no. 1-84. There is no greater prognostic approximation on mortality with PTHbio than PTHi. There was also no difference in mortality when progression ratio PTHbio/PTHi was analysed.
Conclusions:
We didn’t find any advantages to using bioPTH vs. PTHi as a marker of mortality. BioPTH limits of normality must be reevaluated because its relationship with iPTH is not consistent. Not knowing these limits affects its prognostic value.
Palabras clave : Haemodialysis; Parathormone; PTH bio; Intact PTH; Mortality; Cardiovascular.
